D. Donnelly

发表

Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

I. Osman, U. Moran, J. Zhong, 2020, Journal of translational medicine.

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

A. Balar, I. Osman, A. Pavlick, 2019, Journal of Immunotherapy for Cancer.

The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic

I. Osman, U. Moran, C. Arguelles-Grande, 2020, Journal of Translational Medicine.

A Deep Learning Approach for Rapid Mutational Screening in Melanoma

N. Razavian, N. Coudray, T. Sakellaropoulos, 2019, bioRxiv.

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

D. Rimm, N. Coudray, A. Tsirigos, 2020, Clinical Cancer Research.

Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer

Samuel J. Kozloff, I. Osman, J. Zhong, 2020, Journal for ImmunoTherapy of Cancer.

The "-omics" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.

G. Jour, P. Aung, Douglas Donnelly, 2019, Seminars in cancer biology.

Melanoma Prognosis - Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

D. Polsky, I. Osman, A. Pavlick, 2020, Journal of the National Cancer Institute.

Deep learning and pathomics analyses reveal cell nuclei as important features for mutation prediction of BRAF-mutated melanomas.

N. Razavian, N. Coudray, T. Sakellaropoulos, 2021, The Journal of investigative dermatology.

Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients

Samuel J. Kozloff, I. Osman, J. Zhong, 2021, Journal of translational medicine.

The NYU Children’s Health and Environment Study

L. Trasande, D. Fenyo, J. Buyon, 2020, European Journal of Epidemiology.

Genomic and transcriptomic analyses of NF1-mutant melanoma identify potential targeted approach for treatment.

R. Betensky, I. Osman, G. Jour, 2022, The Journal of investigative dermatology.